低分子肝素与普通肝素治疗肺栓塞的安全性比较  

The safety comparison between low molecule heparin and common heparin for the treatment of lung embolism

作　　者：韩凤仙[1] 梁玉英[1] 

机构地区：[1]解放军第211医院,黑龙江哈尔滨150080

出　　处：《护士进修杂志》2000年第6期409-410,共2页Journal of Nurses Training

摘　　要：目的比较低分子肝素和普通肝素治疗肺栓塞的效果的安全性。方法对 35例肺栓塞患者随机选用低分子肝素或普通肝素在治疗前后都以试验室检查及核素肺灌注扫描显像作为评定标准。结果低分子肝素组与普通肝素组治疗后比较两组明显差异 (P <0 .0 5 ) ,低分子肝素组一例出现皮下淤斑 ,普通肝素组一例血尿 ,5例皮下淤斑。结论低分子肝素较普通肝素对肺栓塞治疗效果好 ,而且更具有安全性。Objective Comparing the effect and the security of low molecule heparin treating pulmonary embolism with those of common heparin.Method Seleting low molecule heparin or common heparin to treat thirty five patients of pulmonary embolism randomly. Regarding laboratory examination and ventilation perfusions scanning as the judgment standard around treatment.Result The result is very different between the groups after treatment( P <0.05).Conclusion Low molecule heparin had better effect on pulmonary embolism than that of common heparin and with much more security.

关 键 词：低分子肝素 普通肝素 肺栓塞 安全性 药物疗法 

分 类 号：R563.505[医药卫生—呼吸系统] R973.2[医药卫生—内科学]